| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
3-hydroxybutyrate dehydrogenase 2 | 0.700 | 0.462 | 8.5E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
4-aminobutyrate aminotransferase | 0.628 | 0.538 | 6.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
5', 3'-nucleotidase, cytosolic | 0.729 | 0.231 | 2.7E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
phenotype | 0.040 | None | 1.000 | 4 | 1 | 2015 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2012 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
phenotype | 0.030 | None | 0.667 | 3 | 1 | 2005 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
phenotype | 0.030 | None | 1.000 | 3 | 2 | 2004 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
acid phosphatase 1 | 0.566 | 0.731 | 1.8E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1998 | 2014 | ||||||||
|
actin binding LIM protein family member 3 | 1.000 | 0.077 | 1.1E-07 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
activating transcription factor 7 | 0.751 | 0.192 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2004 | 2017 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
phenotype | 0.020 | None | 1.000 | 2 | 1 | 2012 | 2017 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 33 | 0.636 | 0.423 | 2.1E-15 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2004 |